ADHD study: EWM Training
Official title Target ADHD Executive Working Memory Replication Study
ClinicalTrials.gov ID: NCT06446284
What this study is testing
- What it's testing
- It aims to repeat earlier findings and see if the treatment’s effect on brain targets is linked to real improvements in ADHD symptoms.
- Who it's for
- It is looking for people who have been diagnosed with ADHD.
- What's involved
- Participants will receive the study treatment and take part in tests that measure working memory and ADHD symptoms.
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18. Healthy volunteers may be eligible.
You may be able to join if
- Diagnosis of ADHD
- English speaking
- Right-handed
- \>5th grade reading level
- \>80 IQ level
You likely can't join if
- Braces, metal or implant devices
- Brain abnormality, neurological disorder
- TBI or loss of consciousness\>30 minutes
- Diagnosis of Psychosis, Bipolar Disorder, ASD, PTSD, OCD, SUD, Tourette's Disorder
The study team makes the final eligibility decision.
Where it is enrolling
- Hartford, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hartford, Connecticut, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.